Coherus BioSciences
CHRS • NASDAQ
Coherus BioSciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Dennis Lanfear, with a market cap of $244.3M.
CEODennis Lanfear
Next Earnings
Upcoming earnings announcement for Coherus BioSciences
Date
Monday, May 11, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.28
Revenue Estimate
$14.4M
Earnings History
Past 12 earnings reports for Coherus BioSciences
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 9, 2026 | Q4 2025 | -$0.34Est: -$0.34 | 0.0% | $12.7MEst: $13.7M | -7.0% |  10-K |
| Nov 6, 2025 | Q3 2025 | -$0.33Est: -$0.32 | -3.1% | $11.6MEst: $12.9M | -10.5% | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.34Est: -$0.26 | -30.8% | $10.3MEst: $9.6M | +6.6% | 10-Q |
| May 12, 2025 | Q1 2025 | -$0.35Est: -$0.13 | -169.2% | $7.6M | — | 10-Q |
| Mar 10, 2025 | Q4 2024 | -$0.28Est: -$0.13 | -115.4% | $54.1MEst: $43.9M | +23.4% | 10-K |
| Nov 6, 2024 | Q3 2024 | -$0.01Est: -$0.12 | +91.7% | $70.8MEst: $59.2M | +19.5% | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.14Est: -$0.16 | +12.5% | $65.0MEst: $64.2M | +1.3% | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.32Est: -$0.24 | -33.3% | $77.1MEst: $80.3M | -4.0% | 10-Q |
| Mar 13, 2024 | Q4 2023 | -$0.62Est: -$0.12 | -416.7% | $91.5MEst: $96.4M | -5.1% | 10-K |
| Nov 6, 2023 | Q3 2023 | -$0.27Est: -$0.31 | +12.9% | $74.6MEst: $83.6M | -10.8% | — |
| Aug 2, 2023 | Q2 2023 | -$0.38Est: -$0.52 | +26.9% | $58.7MEst: $50.8M | +15.5% | 10-Q |
| May 8, 2023 | Q1 2023 | -$0.75Est: -$0.57 | -31.6% | $32.4MEst: $47.4M | -31.6% | — |